References
Dormandy J, Mahir M, Ascády G, Balsano F, De Leeuw P, Blombery P, Bousser MG, Clement D, Coffman J, Deutschinoff A, Blétry O, Hampton J, Mahler F, Ohlin P, Rieger H, Stranden E, Turpie AGG, Urai L, Verstraete M (1989) Fate of the patient with chronic leg ischemia. A review article. J Cardiovasc Surg 30: 50–57
Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC (1983) Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. Lancet II: 639–642
Quick CGR, Cotton LT (1982) The measured effect of stopping smoking on intermittent claudication. Br J Surg 69 [Suppl]: 24–26
Larsen OA, Larsen NA (1966) Effect of daily muscular exercise in patients with intermittent claudication. Lancet II: 1093–1096
Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ (1990) Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 4: 135–140
Verhaeghe R, Bounameaux H (1991) Peripheral arterial occlusion: thromboembolism, antithrombotic and thrombolytic therapy. In: Fuster V, Verstraete M (eds) Thrombosis in cardiovascular diseases. Saunders, Philadelphia (in press)
Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 39: 50–97
Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE (1982) Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 104: 66–72
Gillings D, Koch G, Reich T, Stager WJ (1987) Another look at the pentoxifylline efficacy data for intermittent claudication. J Clin Pharmacol 27: 601–609
Lindgärde F, Jelnes R, Björkman H, Adielsson G, Kjellström T, Palmquist I, Stavenow L (1989) Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80: 1549–1556
Cameron HA, Waller PC, Ramsay LE (1988) Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985. Br J Clin Pharmacol 26: 569–576
Coffman JD (1979) Vasodilator drugs in peripheral vascular diseases. N Engl J Med 300: 713–717
Verstraete M (1982) Current therapy for intermittent claudication. Drugs 24: 240–247
Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL (1973) Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 4: 576–581
Reid HL, Dormandy JA, Barnes JA, Lock PF, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet I: 666–668
Angelkort B, Maurin N, Boateng K (1979) Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr Med Res Opin 6: 255–258
Matrai A, Ernst E, Flute PJ, Dormandy JA (1984) Blood filterability in peripheral vascular disease: red cell deformability or cell sticking. Clin Hemorrh 4: 311–325
Bareford D, Lucas GS, Caldwell NM, Stone PCW, Baar S, Stuart J (1985) Erythrocyte deformability in peripheral occlusive arterial disease. J Clin Pathol 38: 135–139
Ehrly AM (1978) The effect of pentoxifylline on the flow properties of human blood. Curr Med Res Opin 5: 608–613
Angelkort B, Spürk P, Habbaba A, Mähder M (1985) Blood flow properties and walking performances in chronic arterial occlusive disease. Angiology 36: 285–292
Schmalzer EA, Chien S (1984) Filterability of subpopulations of leukocytes: effect of pentoxifylline. Blood 64: 542–546
Thao Chan M, Conan F, Roche M, Motta C (1987) Effect of pentoxifylline on the lymphocyte membrane fluidity in peripheral vascular disease patients. In: Mandell GL, Novick WJ (eds) Pentoxifylline and leukocyte function. Hoechst-Roussel Pharmaceuticals Inc, pp 238–244
Clemens MR, Ruess M (1991) The effect of pentoxifylline on erythrocyte membrane and plasma lipids. Eur J Clin Pharmacol 41: 623–624
Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E (1991) The uses of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Eur J Clin Pharmacol 41: 511–515
Johnson WC, Sentissi JM, Baldwin D, Hamilton J, Dion J (1987) Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity? J Vasc Surg 6: 211–216
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verhaeghe, R., Verstraete, M. Pentoxifylline in arterial disease of the legs. Eur J Clin Pharmacol 41, 507–509 (1991). https://doi.org/10.1007/BF00314975
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314975